In summary, BCPRS and BCPRS-related genes (HEY1, IFNA13, NKX2-3, NR2F1, POU5F1, and YY1) can be used to evaluate the immune microenvironment and tumor purity in breast cancer patients. This evidence concerns the gene NKX2-3 and breast carcinoma.